What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Enzyme
Neuroscience, NMDA receptor, Cell biology, Synaptic plasticity and Glutamate receptor are her primary areas of study.
Her Neuroscience research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Amyloid precursor protein and Signal transduction.
In the subject of general Cell biology, her work in Phosphorylation is often linked to Nucleoplasm, thereby combining diverse domains of study.
Her research in Synaptic plasticity intersects with topics in Long-term potentiation and Glutamatergic.
She works mostly in the field of Glutamate receptor, limiting it down to concerns involving Neurotransmission and, occasionally, Neuroinflammation, P3 peptide, Biochemistry of Alzheimer's disease and Experimental autoimmune encephalomyelitis.
Her Postsynaptic potential research incorporates themes from Protein subunit and Glutamatergic synapse.
Her most cited work include:
- A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia (221 citations)
- Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. (195 citations)
- [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. (184 citations)
What are the main themes of her work throughout her whole career to date?
Monica Di Luca mostly deals with Neuroscience, NMDA receptor, Alzheimer's disease, Cell biology and Internal medicine.
Her Neuroscience study combines topics in areas such as Synaptic plasticity, Glutamate receptor, AMPA receptor and ADAM10.
The NMDA receptor study combines topics in areas such as Glutamatergic synapse, Protein subunit and Excitatory postsynaptic potential.
Her studies deal with areas such as Dementia and Degenerative disease as well as Alzheimer's disease.
Monica Di Luca combines subjects such as Dendritic spine, Biochemistry and Postsynaptic potential with her study of Cell biology.
Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Oncology and Genotype.
She most often published in these fields:
- Neuroscience (43.02%)
- NMDA receptor (24.02%)
- Alzheimer's disease (22.35%)
What were the highlights of her more recent work (between 2014-2021)?
- Neuroscience (43.02%)
- NMDA receptor (24.02%)
- Synaptic plasticity (17.88%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Neuroscience, NMDA receptor, Synaptic plasticity, Dendritic spine and Disease.
The study incorporates disciplines such as Fragile X syndrome, Frontotemporal dementia, Glutamate receptor, Glutamatergic and Parkinson's disease in addition to Neuroscience.
Specifically, her work in NMDA receptor is concerned with the study of Postsynaptic density.
Monica Di Luca has researched Synaptic plasticity in several fields, including Synapse, Premovement neuronal activity and Excitatory postsynaptic potential.
Her research integrates issues of Hippocampus and Cell biology in her study of Dendritic spine.
Her Cell biology research is multidisciplinary, relying on both Hippocampal formation, Long-term potentiation and Excitatory synapse.
Between 2014 and 2021, her most popular works were:
- Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome (45 citations)
- NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients. (37 citations)
- Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus (33 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Monica Di Luca mainly focuses on Neuroscience, Dendritic spine, ADAM10, Disease and NMDA receptor.
Her Neuroscience research incorporates elements of Glutamatergic and Metabotropic receptor.
Her Dendritic spine research includes themes of Synaptic plasticity, Disease pathogenesis and Cell biology.
Her work deals with themes such as Excitatory synapse, Postsynaptic potential and Excitatory postsynaptic potential, which intersect with Cell biology.
Her work on Amyloid precursor protein as part of general Disease study is frequently linked to Mechanism, bridging the gap between disciplines.
The various areas that Monica Di Luca examines in her NMDA receptor study include Levodopa and Protein subunit.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
